Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Biologics Introduces Clinical Policy and Therapeutic Intelligence Office

Published: Wednesday, May 01, 2013
Last Updated: Wednesday, May 01, 2013
Bookmark and Share
Biologics is pleased to announce the launch of its Clinical Policy and Therapeutic Intelligence Office.

The department has been established to advance the company’s clinical expertise efforts as it continues to distinguish itself as a leader in complex disease medical management and pharmacy services, specifically within the oncology sector. Leading this initiative will be Ann Steagall, BSN, RN, OCN, Director of Clinical Policy and Mike James, RPh, PhD, Director of Therapeutic Intelligence.
Primary objectives for the department will be to lead the clinical oversight committee, develop care plans and clinical assessments, and facilitate training for clinical and non-clinical Biologics team members and clients.

“Over the years we have discussed the importance of Biologics leading with our clinical expertise both internally and externally. Additionally, it has long been our objective for Biologics to be considered a teaching organization,” said Stuart Frantz, President & Chief Executive Officer at Biologics. “Combine those two concepts and you have the Clinical Policy and Therapeutic Intelligence Office.”

As Director of Clinical Policy, Ann will lead the coordination of all plan language reviews, an important component of the Care Integration program. She will also continue to serve on the Oncology Board of Advisors.

As Director of Therapeutic Intelligence, Mike will assess all new drug entries and expanded uses which include pipeline monitoring. He will support the development of disease specific whitepapers for client and internal education, and will serve on the Oncology Board of Advisors.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Higher Frequency of Huntington's Disease Mutations Discovered
University of Aberdeen study shows that the gene change that causes Huntington's disease is much more common than previously thought.
Revealing the Genetic Causes of Bowel Cancer
A landmark study has given the most detailed picture yet of the genetics of bowel cancer — the UK's fourth most common cancer.
The Epigenetic Influences of Chronic Pain
Researchers at Drexel University College of Medicine are aiming to identify new molecular mechanisms involved in pain.
Fighting Resistant Blood Cancer Cells
Biologists present new findings on chronic myeloid leukemia and possible therapeutic approaches.
Tumor Cells Develop Predictable Characteristics
Scientists have discovered that cancer cells at the edge of a tumor that are close to the surrounding environment are predictably different from the cells within the interior of the tumor.
Mothers Obesity Could be Passed on in mtDNA
Obesity can predispose offspring in multiple generations to metabolic problems.
New Imaging Method Reveals Nanoscale Details about DNA
Enhancement to super-resolution microscopy shows orientation of individual molecules, providing a new window into DNA’s structure and dynamics.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
Naked Mole Rat Exhibits “Extraordinary” Cancer Resistance
Scientists are getting closer to understanding the anti-cancer mechanism of the naked mole rat by making induced pluripotent stem cells.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!